ClinicalTrials.govpublic full text
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia
schizophrenia, h3 antagonist, double blind, histamine, randomised, placebo controlled, cognition, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 867977
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.